The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway.

Ebola virus (EBOV) expresses three different glycoproteins (GPs) from its GP gene. The primary product, soluble GP (sGP), is secreted in abundance during infection. EBOV sGP has been discussed as a potential pathogenicity factor, however, little is known regarding its functional role. Here, we analy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wakako Furuyama, Kyle Shifflett, Heinz Feldmann, Andrea Marzi
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Acceso en línea:https://doaj.org/article/cc83fff300b74ca9a612f028f74f0da2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cc83fff300b74ca9a612f028f74f0da2
record_format dspace
spelling oai:doaj.org-article:cc83fff300b74ca9a612f028f74f0da22021-12-02T20:00:10ZThe Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway.1553-73661553-737410.1371/journal.ppat.1009937https://doaj.org/article/cc83fff300b74ca9a612f028f74f0da22021-09-01T00:00:00Zhttps://doi.org/10.1371/journal.ppat.1009937https://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Ebola virus (EBOV) expresses three different glycoproteins (GPs) from its GP gene. The primary product, soluble GP (sGP), is secreted in abundance during infection. EBOV sGP has been discussed as a potential pathogenicity factor, however, little is known regarding its functional role. Here, we analyzed the role of sGP in vitro and in vivo. We show that EBOV sGP has two different functions that contribute to infectivity in tissue culture. EBOV sGP increases the uptake of virus particles into late endosomes in HEK293 cells, and it activates the mitogen-activated protein kinase (MAPK) signaling pathway leading to increased viral replication in Huh7 cells. Furthermore, we analyzed the role of EBOV sGP on pathogenicity using a well-established mouse model. We found an sGP-dependent significant titer increase of EBOV in the liver of infected animals. These results provide new mechanistic insights into EBOV pathogenicity and highlight EBOV sGP as a possible therapeutic target.Wakako FuruyamaKyle ShifflettHeinz FeldmannAndrea MarziPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 17, Iss 9, p e1009937 (2021)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Wakako Furuyama
Kyle Shifflett
Heinz Feldmann
Andrea Marzi
The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway.
description Ebola virus (EBOV) expresses three different glycoproteins (GPs) from its GP gene. The primary product, soluble GP (sGP), is secreted in abundance during infection. EBOV sGP has been discussed as a potential pathogenicity factor, however, little is known regarding its functional role. Here, we analyzed the role of sGP in vitro and in vivo. We show that EBOV sGP has two different functions that contribute to infectivity in tissue culture. EBOV sGP increases the uptake of virus particles into late endosomes in HEK293 cells, and it activates the mitogen-activated protein kinase (MAPK) signaling pathway leading to increased viral replication in Huh7 cells. Furthermore, we analyzed the role of EBOV sGP on pathogenicity using a well-established mouse model. We found an sGP-dependent significant titer increase of EBOV in the liver of infected animals. These results provide new mechanistic insights into EBOV pathogenicity and highlight EBOV sGP as a possible therapeutic target.
format article
author Wakako Furuyama
Kyle Shifflett
Heinz Feldmann
Andrea Marzi
author_facet Wakako Furuyama
Kyle Shifflett
Heinz Feldmann
Andrea Marzi
author_sort Wakako Furuyama
title The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway.
title_short The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway.
title_full The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway.
title_fullStr The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway.
title_full_unstemmed The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway.
title_sort ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the map kinase signaling pathway.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/cc83fff300b74ca9a612f028f74f0da2
work_keys_str_mv AT wakakofuruyama theebolavirussolubleglycoproteincontributestoviralpathogenesisbyactivatingthemapkinasesignalingpathway
AT kyleshifflett theebolavirussolubleglycoproteincontributestoviralpathogenesisbyactivatingthemapkinasesignalingpathway
AT heinzfeldmann theebolavirussolubleglycoproteincontributestoviralpathogenesisbyactivatingthemapkinasesignalingpathway
AT andreamarzi theebolavirussolubleglycoproteincontributestoviralpathogenesisbyactivatingthemapkinasesignalingpathway
AT wakakofuruyama ebolavirussolubleglycoproteincontributestoviralpathogenesisbyactivatingthemapkinasesignalingpathway
AT kyleshifflett ebolavirussolubleglycoproteincontributestoviralpathogenesisbyactivatingthemapkinasesignalingpathway
AT heinzfeldmann ebolavirussolubleglycoproteincontributestoviralpathogenesisbyactivatingthemapkinasesignalingpathway
AT andreamarzi ebolavirussolubleglycoproteincontributestoviralpathogenesisbyactivatingthemapkinasesignalingpathway
_version_ 1718375747753607168